Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q2 2026 (June 30)5holders −2
0new positions
2sold out
$0.79avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holders were Cerity Partners LLC ($662K), Aristeia Capital, L.L.C. ($57K) and Vestcor Inc ($54K).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q2 2026)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $78K |
All 13F filers, Q1 2026 → Q2 2026: 46,210 shares bought and 65,240 shares sold, net −19,030 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Cerity Partners LLC | — | No change | 827,590 | $662K |
| Aristeia Capital, L.L.C. | — | Add +161.5% | 74,826 | $57K |
| Vestcor Inc | — | No change | 70,832 | $54K |
| Fort Baker Capital Management LP | — | No change | 26,374 | $21K |
| Toronto Dominion Bank | — | No change | 5,170 | $4K |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.